Versor Investments’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Versor Investments’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-570,466	Closed	-$13.7M	–	890
2023 Q1	$13.7M	Buy	+570,466	New	+$7.16M	1.8%	14

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Versor Investments's PRVB Position: Q2 2023 in Review

Versor Investments sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 570,466 shares — an estimated $13.7M sold.

Versor Investments first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $13.7M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Versor Investments reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Versor Investments sold 570,466 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $13.7M.
Versor Investments first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Versor Investments's Provention Bio, Inc. Common Stock position peaked at $13.7M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Versor Investments's 13F filing for Q2 2023, filed 7 Aug 2023.